MaaT Pharma
Founded
2014
2014
Geography
France based
France based
Funding
$20 M
$20 M
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat serious diseases linked to imbalances in the intestinal microbiome. It has developed the first treatment solution based on autologous microbiotherapy. MaaT Pharma envisages a first therapeutic application for patients suffering from leukaemia and bone & joint infections, whose major treatment contributes to dysbiosis. Funded jointly by a team which brings together world-class medical-scientific and entrepreneurial skills, MaaT Pharma has the ambition of becoming a leader in microbiome protection and the treatment of dysbiosis.
Technologies
Microbiome StartupsPosts Mentioning This Company
R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet